Cargando…
Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up
BACKGROUND: To describe persistent symptoms in long COVID-19 non-severe outpatients and report the 6-month clinical recovery (CR) rate. METHODS: Observational study enrolling outpatients (≥ 18 years) with confirmed non-severe COVID-19 (positive nasopharyngeal RT-PCR or presence of SARS-CoV-2 antibod...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832844/ https://www.ncbi.nlm.nih.gov/pubmed/35158095 http://dx.doi.org/10.1016/j.idnow.2022.02.005 |
_version_ | 1784648803507240960 |
---|---|
author | Seang, S. Itani, O. Monsel, G. Abdi, B. Marcelin, A.G. Valantin, M.A. Palich, R. Fayçal, A. Pourcher, V. Katlama, C. Tubiana, R. |
author_facet | Seang, S. Itani, O. Monsel, G. Abdi, B. Marcelin, A.G. Valantin, M.A. Palich, R. Fayçal, A. Pourcher, V. Katlama, C. Tubiana, R. |
author_sort | Seang, S. |
collection | PubMed |
description | BACKGROUND: To describe persistent symptoms in long COVID-19 non-severe outpatients and report the 6-month clinical recovery (CR) rate. METHODS: Observational study enrolling outpatients (≥ 18 years) with confirmed non-severe COVID-19 (positive nasopharyngeal RT-PCR or presence of SARS-CoV-2 antibodies) who consulted for persistent symptoms after the first pandemic wave (March-May 2020). CR was assessed at the 6-month visit and defined as complete (no symptom), partial (persistent symptoms of lower intensity) or lack of recovery (no improvement). RESULTS: Sixty-three patients (79% women, mean age: 48 years) enrolled; main symptoms (mean 81 days after acute infection): asthenia/myalgia (77%), dyspnea (51%), headaches (35%), cough (33%). At 6 months (n = 56), 30% had complete, 57% partial, and 13% lack of recovery. The proportion of patients with > 2 persistent symptoms was 26% at 6 months (main symptoms: dyspnea [54%] and asthenia/myalgia [46%]). CONCLUSION: We observed a slow but high recovery rate at 6 months among these outpatients. |
format | Online Article Text |
id | pubmed-8832844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88328442022-02-14 Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up Seang, S. Itani, O. Monsel, G. Abdi, B. Marcelin, A.G. Valantin, M.A. Palich, R. Fayçal, A. Pourcher, V. Katlama, C. Tubiana, R. Infect Dis Now Short Communication BACKGROUND: To describe persistent symptoms in long COVID-19 non-severe outpatients and report the 6-month clinical recovery (CR) rate. METHODS: Observational study enrolling outpatients (≥ 18 years) with confirmed non-severe COVID-19 (positive nasopharyngeal RT-PCR or presence of SARS-CoV-2 antibodies) who consulted for persistent symptoms after the first pandemic wave (March-May 2020). CR was assessed at the 6-month visit and defined as complete (no symptom), partial (persistent symptoms of lower intensity) or lack of recovery (no improvement). RESULTS: Sixty-three patients (79% women, mean age: 48 years) enrolled; main symptoms (mean 81 days after acute infection): asthenia/myalgia (77%), dyspnea (51%), headaches (35%), cough (33%). At 6 months (n = 56), 30% had complete, 57% partial, and 13% lack of recovery. The proportion of patients with > 2 persistent symptoms was 26% at 6 months (main symptoms: dyspnea [54%] and asthenia/myalgia [46%]). CONCLUSION: We observed a slow but high recovery rate at 6 months among these outpatients. Elsevier Masson SAS. 2022-05 2022-02-11 /pmc/articles/PMC8832844/ /pubmed/35158095 http://dx.doi.org/10.1016/j.idnow.2022.02.005 Text en © 2022 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Seang, S. Itani, O. Monsel, G. Abdi, B. Marcelin, A.G. Valantin, M.A. Palich, R. Fayçal, A. Pourcher, V. Katlama, C. Tubiana, R. Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up |
title | Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up |
title_full | Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up |
title_fullStr | Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up |
title_full_unstemmed | Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up |
title_short | Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up |
title_sort | long covid-19 symptoms: clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832844/ https://www.ncbi.nlm.nih.gov/pubmed/35158095 http://dx.doi.org/10.1016/j.idnow.2022.02.005 |
work_keys_str_mv | AT seangs longcovid19symptomsclinicalcharacteristicsandrecoveryrateamongnonsevereoutpatientsoverasixmonthfollowup AT itanio longcovid19symptomsclinicalcharacteristicsandrecoveryrateamongnonsevereoutpatientsoverasixmonthfollowup AT monselg longcovid19symptomsclinicalcharacteristicsandrecoveryrateamongnonsevereoutpatientsoverasixmonthfollowup AT abdib longcovid19symptomsclinicalcharacteristicsandrecoveryrateamongnonsevereoutpatientsoverasixmonthfollowup AT marcelinag longcovid19symptomsclinicalcharacteristicsandrecoveryrateamongnonsevereoutpatientsoverasixmonthfollowup AT valantinma longcovid19symptomsclinicalcharacteristicsandrecoveryrateamongnonsevereoutpatientsoverasixmonthfollowup AT palichr longcovid19symptomsclinicalcharacteristicsandrecoveryrateamongnonsevereoutpatientsoverasixmonthfollowup AT faycala longcovid19symptomsclinicalcharacteristicsandrecoveryrateamongnonsevereoutpatientsoverasixmonthfollowup AT pourcherv longcovid19symptomsclinicalcharacteristicsandrecoveryrateamongnonsevereoutpatientsoverasixmonthfollowup AT katlamac longcovid19symptomsclinicalcharacteristicsandrecoveryrateamongnonsevereoutpatientsoverasixmonthfollowup AT tubianar longcovid19symptomsclinicalcharacteristicsandrecoveryrateamongnonsevereoutpatientsoverasixmonthfollowup |